media room

NEWS AND MEDIA

NeuRA launches eBook to support Mental Wellness at Work

NeuRA has launched a FREE eBook, Mental Wellness in the Workplace, on world mental health day.

Schizophrenia in the spotlight at Australian Psychosis Conference

The Australian Psychosis Conference was recently held in Sydney, bringing together researchers, clinicians, consumers and carers to discuss the best possible outcomes for people with a psychotic illness. Professor Cindy Shannon Weickert, NSW Chair of Schizophrenia Research, based at NeuRA and UNSW, was a plenary speaker at the event. She discussed her latest research and recent breakthrough in schizophrenia, which has the potential to transform treatment of the illness. Most scientists have had a long-held belief that immune cells were independent from the brain pathology in psychotic illnesses, Professor Shannon Weickert said. “In our study, we challenged this assumption and…

What causes schizophrenia? What we know, don’t know and suspect

Written by Dr Sandy Matheson and originally published on The Conversation  Schizophrenia is one of the world’s top ten causes of disability. It develops between the ages of 16 and 30 and often persists for life. It affects between 100,000 and 200,000 Australians. Symptoms include delusions and hallucinations (“psychotic” symptoms), diminished emotional expression, poverty of speech and lack of purposeful action (known as “negative” symptoms), and incoherent speech and disorganised behaviour (“disorganised” symptoms). A diagnosis of schizophrenia requires at least two symptoms, including one psychotic or disorganised, to be present for at least six months. These must result in significant social or occupational dysfunction….

Can humans live to 150?

The international Living to 100 Conference was recently held in Sydney hosted by the Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney. The conference brought together leaders in the field of ageing from around the globe to debate and unravel the secrets of successful ageing. The internationally acclaimed line up of speakers included NeuRA’s CEO Professor Peter Schofield, NeuRA Senior Research Scientist, Dr Karen Mather and NeuRA Senior Research Facility Manager, Dr Claire Shepherd. Over the two-day conference, experts deliberated on the latest research on exceptionally long-lived individuals, in particular centenarians and supercentenarians. But the question on everyone’s lips was…

Schizophrenia breakthrough

In one of the biggest breakthroughs in schizophrenia research in recent times, Professor Cynthia Shannon Weickert at Neuroscience Research Australia (NeuRA) has identified immune cells in greater amounts in the brains of some people with schizophrenia. The study published today in Molecular Psychiatry has the potential to transform global schizophrenia research and open new avenues for developing targeted immune cell therapies. One in every 100 Australians lives with schizophrenia. No single cause of schizophrenia has been identified, and this has prevented the development of a cure. The current treatments for schizophrenia are designed to suppress symptoms rather than target underlying…

Calls to prioritise osteoporosis plans for hip fracture patients leaving hospital

The Australian and New Zealand Hip Fracture Registry based at Neuroscience Research Australia (NeuRA), released its 2018 report today and the authors are calling for hospitals to make osteoporosis plans a priority for patients leaving hospital after a hip fracture. Data from the report shows only 25 per cent of hip fracture patients leave hospital on active treatment for osteoporosis and only 24 per cent of hospitals provide individualised written information on prevention of future falls and fractures.    Commenting on the report, Professor Jacqueline Close, Geriatrician and Co-Chair of the Australian and New Zealand Hip Fracture Registry (ANZHFR) said…